Gagnon Advisors, LLC Maxcyte, Inc. Transaction History
Gagnon Advisors, LLC
- $125 Million
- Q1 2025
A detailed history of Gagnon Advisors, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Gagnon Advisors, LLC holds 934,196 shares of MXCT stock, worth $2.09 Million. This represents 2.05% of its overall portfolio holdings.
Number of Shares
934,196Holding current value
$2.09 Million% of portfolio
2.05%Shares
1 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
71.6MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$22.5 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$18.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$15.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$12.5 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$11.3 Million13.13% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $228M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...